Yifan Wang

机构：The University of Texas MD Anderson Cancer Center, Dalian Medical University, Second Affiliated Hospital of Dalian Medical University · ORCID：0000-0001-7056-6251

发表论文 9 篇 · 总被引 281 次 · h-index 4

代表论文

• Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis (2022 · Science Advances · 被引 231)
• Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases (2025 · Frontiers in Immunology · 被引 33)
• Evaluating the therapeutic potential of tofacitinib in Sjögren’s disease: a comprehensive clinical and immunological assessment (2025 · Lara D. Veeken · 被引 9)
• Validation of the clinical assessment scale for autoimmune encephalitis in a severe autoimmune encephalitis cohort (2024 · Frontiers in Immunology · 被引 6)
• FACS-based genome-wide CRISPR screening platform identifies modulators of CD47 (2026 · Frontiers in Immunology · 被引 1)
• Guidelines for the management of pancreatic cystic lesions: many options, too few solutions? (2025 · HepatoBiliary Surgery and Nutrition · 被引 1)